Opinion: Genome sequencing can lead to life-changing care for infants. California should make it more available

Innovative medical technology is constantly being developed, and with it comes the possibility for incredible breakthroughs in modern medicine. California has never seen scientific advancements within closer reach than they are today. For critically ill infants hospitalized with unexplained rare diseases, the opportunity to benefit from a medical miracle has arrived.

Parents, Doctors Agree: Genome Sequencing as a First-Tier Diagnostic Test Benefits Critically Ill Infants
Rapid Whole Genome Sequencing is making a difference in babies' and families' lives. Photo by Earnie Grafton.

Parents, Doctors Agree: Genome Sequencing as a First-Tier Diagnostic Test Benefits Critically Ill Infants

Findings of two new studies by Rady Children’s Institute for Genomic Medicine

SAN DIEGO – Nov. 5, 2020— A vast majority of doctors and parents of babies in intensive care, with diseases of unknown origin, believe genomic sequencing is beneficial in managing care, according to two new papers published by Rady Children’s Institute for Genomic Medicine. Read More

Genomenon and Rady Children’s Institute for Genomic Medicine Collaborate to Accelerate Diagnosis of Rare Genetic Disorders in Newborns

Mastermind Genomic Search Engine Now Part of RCIGM’s Analysis and Variant Interpretation Workflow

Ann Arbor, Michigan – October 6, 2020 The Rady Children’s Institute for Genomic Medicine (RCIGM) and Genomenon, Inc. today announced a strategic collaboration to accelerate the diagnosis of critically-ill newborns with rare genetic disorders. The collaboration combines the Institute’s genomic research expertise with Genomenon’s Mastermind Genomic Search Engine to advance precision medicine for infants in an intensive care setting. Read More